2018-05-05 07:33:00 Sat ET
trust perseverance resilience empathy compassion passion purpose vision mission life metaphors seamless integration critical success factors personal finance entrepreneur inspiration grit
Warren Buffett shares his fresh economic insights and value investment strategies at the Berkshire Hathaway shareholder forum in May 2018 despite the new GAAP accounting rule that has led to a $1.14 billion net loss for the Buffett-Munger stock portfolio. Berkshire reports a $1.14 billion loss in 2018Q1 or its first net loss since 2009 due to an esoteric GAAP accounting rule that Buffett considers a nightmare. The firm also reports an operating profit of 48.7% year-over-year. The new GAAP rule suggests that the change in investment gains and losses must be shown in all net income figures. This requirement produces some wild and capricious gyrations in the GAAP bottom-line.
Berkshire owns $170 billion tradable stocks, and the market values of these stock positions can easily fluctuate by $10 billion or more within each quarter. Including gyrations of such magnitude in net income swamps the more important numbers that better describe Berkshire Hathaway's true operating performance. Buffett thus pierces the key GAAP veil for Berkshire investors to better assess the fundamental intrinsic value of each stock position. Buffett continues his active interest in small-to-mid-cap profitable value stocks that inject capital conservatively in both capital equipment and balance sheet expansion.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-06-07 04:02:05 Friday ET
The world seeks to reduce medicine prices and other health care costs to better regulate big pharma. Nowadays the Trump administration requires pharmaceutic
2024-05-05 10:31:00 Sunday ET
Stock Synopsis: Pharmaceutical post-pandemic patent development cycle In terms of stock market valuation, the major pharmaceutical sector remains at its
2025-07-01 13:35:00 Tuesday ET
In recent times, financial deglobalization and asset market fragmentation can cause profound public policy implications for trade, finance, and technology w
2019-10-09 16:46:00 Wednesday ET
IMF chief economist Gita Gopinath indicates that competitive currency devaluation may be an ineffective solution to improving export prospects. In the form
2019-07-23 09:22:00 Tuesday ET
Harvard economic platform researcher Dipayan Ghosh proposes some alternative solutions to breaking up tech titans such as Facebook, Google, Apple, and Amazo
2019-08-30 11:35:00 Friday ET
The conventional wisdom suggests that chameleons change their skin coloration to camouflage their presence for survival through Darwinian biological evoluti